Albireo Pharma Inc (ALBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALBO | ANNX | SLS | ||
| Company | Albireo Pharma Inc | Annexon Inc | Sellas Life Sciences Group Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 44.90 | 5.85 | 4.95 | ||
| High | 44.90 | 5.96 | 5.03 | ||
| Low | 43.99 | 5.72 | 4.88 | ||
| Latest | 44.15 | 5.75 | 4.93 | ||
| Change | -0.10 | -0.12 | -0.02 | ||
| % Change | -0.23% | -2.04% | -0.40% | ||
| Volume | 1,241,200 | 1,233,900 | 2,671,800 | ||
| 20-Day Average Volume | 635,260 | 2,229,090 | 4,462,830 | ||
| Previous Close | 44.25 | 5.87 | 4.95 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 44.18 | 6.05 | 4.83 | ||
| 20-Day Raw Stochastic | 43.90% | 25.11% | 57.48% | ||
| 20-Day Relative Strength | 72.09 | 49.01 | 52.26 | ||
| Weighted Alpha | +16.30 | +96.03 | +130.14 | ||
| Today's Opinion | 88% Buy | 88% Buy | 72% Buy | ||
| Previous Opinion | 100% Buy | 88% Buy | 72% Buy | ||
| Last Month's Opinion | 100% Buy | 40% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.28% since 02/23/23 | -2.21% since 04/24/26 | +10.54% since 04/24/26 | ||
| Low | 43.53 on 02/24/23 | 5.72 on 05/01/26 | 4.63 on 04/27/26 | ||
| High | 44.90 on 03/02/23 | 6.26 on 04/28/26 | 5.03 on 05/01/26 | ||
| 1-Month | |||||
| %Chg | -0.90% since 02/02/23 | +7.28% since 04/01/26 | +17.10% since 04/01/26 | ||
| Low | 43.31 on 02/23/23 | 5.13 on 04/02/26 | 4.02 on 04/02/26 | ||
| High | 45.23 on 02/03/23 | 6.61 on 04/17/26 | 5.47 on 04/20/26 | ||
| 3-Month | |||||
| %Chg | +85.66% since 12/02/22 | -7.85% since 01/30/26 | +30.77% since 01/30/26 | ||
| Low | 17.78 on 12/27/22 | 4.78 on 02/23/26 | 3.46 on 02/12/26 | ||
| High | 45.23 on 02/03/23 | 6.61 on 04/17/26 | 6.14 on 03/09/26 | ||
| 6-Month | |||||
| %Chg | +156.84% since 09/02/22 | +81.96% since 10/31/25 | +170.88% since 10/31/25 | ||
| Low | 16.02 on 09/07/22 | 2.54 on 11/13/25 | 1.39 on 12/02/25 | ||
| High | 45.23 on 02/03/23 | 7.18 on 01/23/26 | 6.14 on 03/09/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 913,949 | 934,415 | 909,748 | ||
| Shares Outstanding, K | 20,701 | 162,507 | 184,533 | ||
| Annual Sales | 40,580,000 | 0 | 0 | ||
| Annual Net Income | -34,030,000 | -206,690,000 | -26,860,000 | ||
| Last Quarter Sales | 9,830,000 | 0 | 0 | ||
| Last Quarter Net Income | -37,800,000 | -48,260,000 | -7,660,000 | ||
| 60-Month Beta | 1.03 | 1.22 | 2.24 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.89 on 11/08/22 | -0.28 on 03/30/26 | -0.05 on 03/19/26 | ||
| Earnings Date | 03/07/23 | 05/11/26 | 05/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||